What does CUSIP 23255M105 represent in this 13F holders report?

CUSIP 23255M105 is the security identifier for CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in Q2 2019?

93 institutional investors reported CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK for Q2 2019. Use the holders table for investor-level position and value details.

CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class: Equity / COMMON STOCK
Total 13F shares: 19,469,585
Total 13F value: $222,922,553
Share change: +18,613,008
SEC-reported price per share: $11.45
Number of holders: 93
Value change: +$213,114,445
Number of buys: 91
Number of sells: 1
Shares outstanding: 4,330,313

Security key

23255M105

Report period

Q2 2019

Institutions

Top holders

CYCN full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2019 Previous quarter: Q1 2019 Cyclerion Therapeutics, Inc. SEC filings Cyclerion Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 23255M105

Newer quarter: Q3 2019 Previous quarter: Q1 2019

Recent filing periods:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Ownership snapshot

Top reported holders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FARALLON CAPITAL MANAGEME...

Disclosed value leader

FARALLON CAPITAL MANAGEME...

Comparable rows

3/3

Latest evidence

31 Mar 2019

13F Lead comparable stake: 19%

Quick read

FARALLON CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 19%.

3 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FARALLON CAPITAL MANAGEMENT LLC's linked filing trail.

Comparable ownership Top 3

FARALLON CAPITAL MANAGEMENT LLC 19%

NORTHERN TRUST CORP 0.25%

CWM, LLC 0.01%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-3 of 3 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FARALLON CAPITAL MANAGEMENT LLC	13F Company 13F	19%	$12,500,000 844,085 shares	—	31 Mar 2019
NORTHERN TRUST CORP	13F Company 13F	0.25%	$165,000 10,674 shares	—	31 Mar 2019
CWM, LLC	13F Company 13F	0.01%	$1,000 297 shares	—	31 Mar 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

19,469,585

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q2 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend